arrow_back Back to App

Hypertrophic Cardiomyopathy Awareness Day: Supporting Heart Health

The U.S. House of Representatives supports designating the fourth Wednesday of February as Hypertrophic Cardiomyopathy Awareness Day. This aims to increase public knowledge about this often undiagnosed heart condition, which is crucial for early detection and treatment, thereby improving citizens' quality of life.
Key points
Establishing Hypertrophic Cardiomyopathy Awareness Day seeks to educate the public about the symptoms and risks of this heart disease.
Increased awareness can lead to quicker diagnosis and treatment, which is vital as the condition is often mistaken for other ailments.
Early detection and proper management can significantly reduce the risk of severe complications like heart failure or sudden cardiac death.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_HRES_305
Sponsor: Rep. LaHood, Darin [R-IL-16]
Process start date: 2025-04-08
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Expressing support for the designation of the fourth Wednesday of February as "Hypertrophic Cardiomyopathy Awareness Day".

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_HRES_305.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2025-04-08.

What are the main provisions?

Key points include:

  • Establishing Hypertrophic Cardiomyopathy Awareness Day seeks to educate the public about the symptoms and risks of this heart disease.
  • Increased awareness can lead to quicker diagnosis and treatment, which is vital as the condition is often mistaken for other ailments.
  • Early detection and proper management can significantly reduce the risk of severe complications like heart failure or sudden cardiac death.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. LaHood, Darin [R-IL-16].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-21.

CATEGORIES

Health